{
    "info": {
        "nct_id": "NCT03476330",
        "official_title": "Quercetin Chemoprevention for Squamous Cell Carcinoma in Patients With Fanconi Anemia",
        "inclusion_criteria": "* Diagnosis of FA\n* Able to take enteral medication\n* Patients ≥2 years\nHealthy volunteers allowed\nMust have minimum age of 2 Years",
        "exclusion_criteria": "* Renal failure requiring dialysis\n* Total bilirubin >3 mg/dl and/or SGPT >200 at time of enrollment\n* Patients receiving digoxin therapy, who are unable to discontinue either treatment due to medical reasons\n* Patients who are pregnant or breastfeeding or are at risk of pregnancy or fathering a baby and are unable to use acceptable methods of birth control during the length of the study\n* Patients who have received quercetin supplementation or other antioxidants within the last 30 days\n* Patients receiving radiation therapy, chemotherapy or immunotherapy for treatment of SCC.",
        "miscellaneous_criteria": ""
    },
    "inclusion_lines": [
        {
            "line": "Must have minimum age of 2 Years",
            "criterions": [
                {
                    "exact_snippets": "minimum age of 2 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 2,
                                "unit": "Years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "Healthy volunteers allowed",
            "criterions": [
                {
                    "exact_snippets": "Healthy volunteers allowed",
                    "criterion": "healthy volunteer status",
                    "requirements": [
                        {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Able to take enteral medication",
            "criterions": [
                {
                    "exact_snippets": "Able to take enteral medication",
                    "criterion": "ability to take enteral medication",
                    "requirements": [
                        {
                            "requirement_type": "ability",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Diagnosis of FA",
            "criterions": [
                {
                    "exact_snippets": "Diagnosis of FA",
                    "criterion": "FA diagnosis",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Patients ≥2 years",
            "criterions": [
                {
                    "exact_snippets": "Patients ≥2 years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum age",
                            "expected_value": {
                                "operator": ">=",
                                "value": 2,
                                "unit": "years"
                            }
                        }
                    ]
                }
            ]
        }
    ],
    "exclusion_lines": [
        {
            "line": "* Patients receiving digoxin therapy, who are unable to discontinue either treatment due to medical reasons",
            "criterions": [
                {
                    "exact_snippets": "Patients receiving digoxin therapy",
                    "criterion": "digoxin therapy",
                    "requirements": [
                        {
                            "requirement_type": "current use",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "unable to discontinue either treatment due to medical reasons",
                    "criterion": "ability to discontinue digoxin therapy",
                    "requirements": [
                        {
                            "requirement_type": "ability to discontinue",
                            "expected_value": false
                        },
                        {
                            "requirement_type": "reason for inability to discontinue",
                            "expected_value": "medical reasons"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Patients receiving radiation therapy, chemotherapy or immunotherapy for treatment of SCC.",
            "criterions": [
                {
                    "exact_snippets": "Patients receiving radiation therapy ... for treatment of SCC",
                    "criterion": "radiation therapy",
                    "requirements": [
                        {
                            "requirement_type": "current treatment",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "indication",
                            "expected_value": "squamous cell carcinoma (SCC)"
                        }
                    ]
                },
                {
                    "exact_snippets": "Patients receiving ... chemotherapy ... for treatment of SCC",
                    "criterion": "chemotherapy",
                    "requirements": [
                        {
                            "requirement_type": "current treatment",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "indication",
                            "expected_value": "squamous cell carcinoma (SCC)"
                        }
                    ]
                },
                {
                    "exact_snippets": "Patients receiving ... immunotherapy for treatment of SCC",
                    "criterion": "immunotherapy",
                    "requirements": [
                        {
                            "requirement_type": "current treatment",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "indication",
                            "expected_value": "squamous cell carcinoma (SCC)"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Total bilirubin >3 mg/dl and/or SGPT >200 at time of enrollment",
            "criterions": [
                {
                    "exact_snippets": "Total bilirubin >3 mg/dl",
                    "criterion": "total bilirubin",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">",
                                "value": 3,
                                "unit": "mg/dl"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "SGPT >200 at time of enrollment",
                    "criterion": "SGPT",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">",
                                "value": 200,
                                "unit": ""
                            }
                        },
                        {
                            "requirement_type": "time",
                            "expected_value": "at time of enrollment"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Patients who have received quercetin supplementation or other antioxidants within the last 30 days",
            "criterions": [
                {
                    "exact_snippets": "received quercetin supplementation ... within the last 30 days",
                    "criterion": "quercetin supplementation",
                    "requirements": [
                        {
                            "requirement_type": "recency",
                            "expected_value": {
                                "operator": "<=",
                                "value": 30,
                                "unit": "days"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "received ... other antioxidants within the last 30 days",
                    "criterion": "other antioxidants supplementation",
                    "requirements": [
                        {
                            "requirement_type": "recency",
                            "expected_value": {
                                "operator": "<=",
                                "value": 30,
                                "unit": "days"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Renal failure requiring dialysis",
            "criterions": [
                {
                    "exact_snippets": "Renal failure requiring dialysis",
                    "criterion": "renal failure",
                    "requirements": [
                        {
                            "requirement_type": "severity",
                            "expected_value": "requiring dialysis"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Patients who are pregnant or breastfeeding or are at risk of pregnancy or fathering a baby and are unable to use acceptable methods of birth control during the length of the study",
            "criterions": [
                {
                    "exact_snippets": "Patients who are pregnant",
                    "criterion": "pregnancy status",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "breastfeeding",
                    "criterion": "breastfeeding status",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "at risk of pregnancy",
                    "criterion": "risk of pregnancy",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "at risk of ... fathering a baby",
                    "criterion": "risk of fathering a baby",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "unable to use acceptable methods of birth control during the length of the study",
                    "criterion": "use of acceptable methods of birth control",
                    "requirements": [
                        {
                            "requirement_type": "ability to use",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "duration",
                            "expected_value": "during the length of the study"
                        }
                    ]
                }
            ]
        }
    ],
    "miscellaneous_lines": [],
    "failed_inclusion": [],
    "failed_exclusion": [],
    "failed_miscellaneous": []
}